Cornex Gel
NDC Package 82160-238-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cornex (lactic acid, salicylic acid) gel is cornex is used to remove Warts and Corns. This formulation utilizes a gel delivery system. Marketed by Pella Pharmaceuticals Co. Ltd, this product is identified by NDC 82160-238.

Identification & Billing

NDC Package Code
82160-238-01
Package Description
1 TUBE in 1 CARTON / 15 g in 1 TUBE
Product Code
82160-238
11-Digit Billing Format
82160023801
RxNorm Crosswalk
  • RxCUI: 244534 - lactic acid 16.7 % / salicylic acid 16.7 % Topical Gel
  • RxCUI: 244534 - lactic acid 0.167 MG/MG / salicylic acid 0.167 MG/MG Topical Gel
  • RxCUI: 244534 - lactic acid 167 MG / salicylic acid 167 MG per 1 GM Topical Gel

Clinical Specifications

Proprietary Name
Cornex
Non-Proprietary Name
Lactic Acid, Salicylic Acid
Substance Name
Lactic Acid; Salicylic Acid
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Acidifying Activity - [MoA] (Mechanism of Action)
Usage Information
Cornex is used to remove Warts and Corns. A wart is a viral infection of the skin surface layer. The incubation period varies from a few weeks to several months. Warts can be spread by contact of the virus with damaged skin, particularly if warm and moist. This is why one of the most common sources of infection is swimming pools. Corns are hard, thick pads of skin caused by pressure and friction. They usually occur on the feet due to poorly fitting shoes. They can also occur on hands. Cornex Gel is suitable for use by adults, children and the elderly.

Regulatory & Marketing

Labeler Name
Pella Pharmaceuticals Co. Ltd
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
03-25-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82160-238-01 identifies a specific commercial package of 1 tube in 1 carton / 15 g in 1 tube of Cornex, a human over the counter drug labeled by Pella Pharmaceuticals Co. Ltd. This gel is formulated for topical use and contains lactic acid; salicylic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pella Pharmaceuticals Co. Ltd on March 25, 2010. The current certification is valid through December 31, 2026.

How is this Pella Pharmaceuticals Co. Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82160023801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82160-238-01
11-Digit CMS (5-4-2)
82160-0238-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.